Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dougados

Showing results (311-320 of 362) with videos related to

Pageof 37
Sort By:
Osteoarthritis and Cartilage|February 24, 2009
OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritisP Ornetti, K Brandt, M-P Hellio-Le Graverand, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Genes and Immunity|October 22, 2004
DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targetsV Devauchelle, S Marion, N Cagnard, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Arthritis and Rheumatism|May 28, 2010
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryJ-E Gottenberg, P Ravaud, T Bardin, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyR Landewé, J Braun, A Deodhar, et al.
Arthritis Care & Research|June 8, 2012
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational studyF Tubach, P Ravaud, E Martin-Mola, et al.
Annals of the Rheumatic Diseases|May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utilityP Conaghan, M A D'Agostino, P Ravaud, et al.
Annals of the Rheumatic Diseases|January 7, 2006
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)B Combe, R Landewe, C Lukas, et al.
Pageof 37

Showing results (311-320 of 362) with videos related to

Sort By:
Pageof 37
Osteoarthritis and Cartilage|February 24, 2009
OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritisP Ornetti, K Brandt, M-P Hellio-Le Graverand, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Genes and Immunity|October 22, 2004
DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targetsV Devauchelle, S Marion, N Cagnard, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Arthritis and Rheumatism|May 28, 2010
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryJ-E Gottenberg, P Ravaud, T Bardin, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyR Landewé, J Braun, A Deodhar, et al.
Arthritis Care & Research|June 8, 2012
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational studyF Tubach, P Ravaud, E Martin-Mola, et al.
Annals of the Rheumatic Diseases|May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utilityP Conaghan, M A D'Agostino, P Ravaud, et al.
Annals of the Rheumatic Diseases|January 7, 2006
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)B Combe, R Landewe, C Lukas, et al.
Pageof 37